Intravenous Immunoglobulin Treatment of Pediatric Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Review of the Literature

Authors

  • Ayşegül Akan
  • Mustafa Erkoçoğlu
  • Ayşenur Kaya
  • Müge Toyran
  • Ersoy Civelek
  • Zeynep Savaş
  • Dilek Azkur
  • Emine Dibek Mısırlıoğlu
  • Can Naci Kocabaş

Keywords:

Stevens-Johnson syndrome, toxic epidermal necrolysis, child, intravenous immunoglobulin

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), frequently triggered by medications, are the most severe cutaneous reactions. The prodromal symptoms like fever, sore throat and malaise are followed by purpuric atypical target lesions, vesicular lesions, extensive exfoliation and desquamation in the skin as a consequence of generalized epidermal necrosis. Intravenous immunoglobulin (IVIG) is the potential immunomodulator therapy used for SJS/TEN. In this study, three children with SJS,TEN and SJS/TEN overlap who were treated successfully with IVIG were reported.

Downloads

Download data is not yet available.

Published

2013-12-15

How to Cite

1.
Akan A, Erkoçoğlu M, Kaya A, Toyran M, Civelek E, Savaş Z, Azkur D, Dibek Mısırlıoğlu E, Kocabaş CN. Intravenous Immunoglobulin Treatment of Pediatric Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Review of the Literature. AAI [Internet]. 2013 Dec. 15 [cited 2022 Jan. 27];11(3):197-203. Available from: https://aai.org.tr/index.php/aai/article/view/153

Issue

Section

Case Reports